Following adults after a new stroke to study future risks
Follows adults with a new ischemic stroke for 36 months to study later complications.
Plain-language title generated from the registry record
Registry title: Prospective Cohort With Incident Stroke
Key facts
- Where
- Berlin and Munich, GermanySee the 2 sites
Where in Germany
- Center for Stroke Research Berlin, Charité Universitätsmedizin BerlinBerlin, GermanyNo longer taking part
- Interdisciplinary Stroke Center Munich, Klinikum der Universität MünchenMunich, GermanyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Ludwig-Maximilians - University of Munich
- Trial code
- NCT01364168
- Record updated
- 19 March 2024
- Original description
The primary aim of the study is to derive and validate risk scores for vascular endpoints (recurrent stroke, myocardial infarction, and other complications of stroke) and for death following an incident stroke. For this purpose patients with an incident stroke will be followed for 36 months with additional assessments at 3, 12, 24 and 36 months.Read full original descriptionShow less
Prospective Cohort With Incident Stroke
The primary aim of the study is to derive and validate risk scores for vascular endpoints (recurrent stroke, myocardial infarction, and other complications of stroke) and for death following an incident stroke. For this purpose patients with an incident stroke will be followed for 36 months with additional assessments at 3, 12, 24 and 36 months.
Inclusion: Age ≥18 years; Language: German; First ever acute ischemic stroke that occurred with stroke onset in the last 7 days; Written informed consent by patient prior to study participation; Willingness to participate in follow-up.
Exclusion: Prior stroke (definition according to WHO criteria); Patients presenting brain tumour or brain metastasis; Participation in an intervention- / AMG-study.